跳至主要内容
临床试验/JPRN-UMIN000015426
JPRN-UMIN000015426已完成2 期

Assessment of safety and effectiveness of once-daily administration of intravenous busulfan for allogeneic hematopoietic stem cell transplantation - Once-daily ivBu for Allo-HSCT

Toranomon Hospital0 个研究点目标入组 10 人开始时间: 2014年11月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Patients who have active malignant diseases other than hematological diseases (2) Patients who have poorly controlled psychiatric diseases (3) Patients who have active infection (4) Patients who have history of hypersensitivity against ivBu (5) Patients who are pregnant or suspected pregnancy, or are lactating (6) Patients who are considered to be not appropriate candidates for participation by attending physicians

研究者

相似试验